Online citations, reference lists, and bibliographies.
← Back to Search

Formation Of Itraconazole–Succinic Acid Cocrystals By Gas Antisolvent Cocrystallization

Courtney A. Ober, R. B. Gupta
Published 2012 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Cocrystals of itraconazole, an antifungal drug with poor bioavailability, and succinic acid, a water-soluble dicarboxylic acid, were formed by gas antisolvent (GAS) cocrystallization using pressurized CO2 to improve itraconazole dissolution. In this study, itraconazole and succinic acid were simultaneously dissolved in a liquid solvent, tetrahydrofuran, at ambient conditions. The solution was then pressurized with CO2, which decreased the solvating power of tetrahydrofuran and caused crystallization of itraconazole–succinic acid cocrystals. The cocrystals prepared by GAS cocrystallization were compared to those produced using a traditional liquid antisolvent, n-heptane, for crystallinity, chemical structure, thermal behavior, size and surface morphology, potential clinical relevance, and stability. Powder X-ray diffraction, Fourier transform infrared spectroscopy, differential scanning calorimetry, and scanning electron microscopy analyses showed that itraconazole–succinic acid cocrystals with physical and chemical properties similar to cocrystals produced using a traditional liquid antisolvent technique can be prepared by CO2 antisolvent cocrystallization. The dissolution profile of itraconazole was significantly enhanced through GAS cocrystallization with succinic acid, achieving over 90% dissolution in less than 2 h. The cocrystals appeared stable against thermal stress for up to 4 weeks under accelerated stability conditions, showing only moderate decreases in their degree of crystallinity but no change in their crystalline structure. This study shows the utility of an itraconazole–succinic acid cocrystal for improving itraconazole bioavailability while also demonstrating the potential for CO2 to replace traditional liquid antisolvents in cocrystal preparation, thus making cocrystal production more environmentally benign and scale-up more feasible.
This paper references
10.1016/J.SUPFLU.2008.05.010
Recrystallization of caffeine using gas antisolvent process
S. Park (2008)
Itraconazole: comprehensive profile . Profiles Drug Subst Excip Relat Methodol
Aa Al-Badr (2009)
10.1021/CG060777P
Designing Hydrogen Bonds with Temperature-Dependent Proton Disorder: The Effect of Crystal Environment
A. Parkin (2007)
10.3109/03639045.2011.633263
Powder X-ray diffraction method for the quantification of cocrystals in the crystallization mixture
Luís Padrela (2012)
CIS-itraconazole crystalline forms and related processes, pharmaceutical compositions and methods
J Remenar (2006)
Agglomerates by crystallization
J Booij (2005)
CIS-itraconazole crystalline forms and related processes, pharmaceutical compositions and methods. Google Patents
J Remenar (2006)
10.1007/s11095-007-9394-1
Indomethacin–Saccharin Cocrystal: Design, Synthesis and Preliminary Pharmaceutical Characterization
S. Basavoju (2007)
10.1016/j.ejps.2009.05.010
Formation of indomethacin-saccharin cocrystals using supercritical fluid technology.
Luís Padrela (2009)
10.1016/S0378-5173(02)00326-5
Comparative physicochemical properties of hydrocortisone-PVP composites prepared using supercritical carbon dioxide by the GAS anti-solvent recrystallization process, by coprecipitation and by spray drying.
O. Corrigan (2002)
10.1016/J.POWTEC.2012.04.058
Formation of itraconazole/L-malic acid cocrystals by gas antisolvent cocrystallization
Courtney A. Ober (2013)
10.1002/JPS.20535
Phase solubility and inclusion complex of itraconazole with beta-cyclodextrin using supercritical carbon dioxide.
A. Al-Marzouqi (2006)
10.1016/S0022-0248(96)01190-6
Crystal size control of sulfathiazole using high pressure carbon dioxide
M. Kitamura (1997)
10.1002/CRAT.200711102
Optical and dielectric studies on succinic acid single crystals
S. Krishnan (2008)
10.1016/J.SUPFLU.2004.12.010
Precipitation and phase behavior of theophylline in solvent-supercritical CO2 mixtures
P. Subra (2005)
10.1021/JS9700661
Pharmaceutical processing with supercritical carbon dioxide.
B. Subramaniam (1997)
10.1021/JA035776P
Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.
Julius F. Remenar (2003)
10.1021/CG801039J
Solubility Advantage of Pharmaceutical Cocrystals
D. Good (2009)
10.1016/S0896-8446(02)00094-3
Recrystallization of sulfathiazole and chlorpropamide using the supercritical fluid antisolvent process
Sang-Do Yeo (2003)
10.1021/ja907674c
Using cocrystals to systematically modulate aqueous solubility and melting behavior of an anticancer drug.
C. Aakeröy (2009)
10.1021/JF960688S
Development of an Enzyme-Linked Immunosorbent Assay for Azadirachtins †
S. Schuetz (1997)
10.1016/j.ijpharm.2011.07.037
Pharmaceutical cocrystals: an overview.
Ning Qiao (2011)
10.1016/S0731-7085(01)00414-9
Formulation and evaluation of itraconazole via liquid crystal for topical delivery system.
D. Nesseem (2001)
10.1016/J.SUPFLU.2010.01.010
Screening for pharmaceutical cocrystals using the supercritical fluid enhanced atomization process
L. Padrela (2010)
10.1016/J.SUPFLU.2011.05.012
Theophylline polymorphs by atomization of supercritical antisolvent induced suspensions
M. Rodrigues (2011)
10.1021/CG800183V
Co-Crystal Polymorphs from a Solvent-Mediated Transformation
J. Horst (2008)
10.1016/J.IJPHARM.2006.04.018
Physical stability enhancement of theophylline via cocrystallization.
A. Trask (2006)
10.1021/CG700843S
Improving Mechanical Properties of Caffeine and Methyl Gallate Crystals by Cocrystallization
C. Sun (2008)
10.1002/ADMA.200900533
Improving Mechanical Properties of Crystalline Solids by Cocrystal Formation: New Compressible Forms of Paracetamol
S. Karki (2009)
10.1002/AIC.690420213
Crystallization of phenanthrene from toluene with carbon dioxide by the GAS process
E. M. Berends (1996)
10.1002/CRAT.200710981
Growth and characterization of succinic acid single crystals
S. Krishnan (2007)
10.1016/J.SUPFLU.2011.03.002
Effect of CO2-antisolvent techniques on size distribution and crystal lattice of theophylline
C. Roy (2011)
10.1039/C0GC00205D
Solubility of bio-sourced feedstocks in ‘green’ solvents
S. Payne (2010)
10.1007/S11814-008-0097-Z
Recrystallization of phenylbutazone using supercritical fluid antisolvent process
S. Park (2008)
10.1002/AIC.690441004
Fractional crystallization by gas antisolvent technique: Theory and experiments
A. Bertucco (1998)
10.1002/JPS.1113
Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques.
N. Elvassore (2001)
10.1002/jps.22524
Single-step preparation and deagglomeration of itraconazole microflakes by supercritical antisolvent method for dissolution enhancement.
S. Sathigari (2011)
10.1039/B801713C
A rapid thermal method for cocrystal screening
E. Lu (2008)
10.1038/nrd1280
Crystal structures of drugs: advances in determination, prediction and engineering
S. Datta (2004)
10.1016/J.SUPFLU.2010.09.009
Formulation development of Carbamazepine–Nicotinamide co-crystals complexed with γ-cyclodextrin using supercritical fluid process
Abhijat Shikhar (2011)
Pharmaceutical co-crystal compositions. Google Patents
à Almarsson (2011)
10.1016/J.ADDR.2003.10.020
High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
S. Morissette (2004)
10.1007/B100995
Crystal Engineering of Organic Cocrystals by the Solid-State Grinding Approach
A. Trask (2005)
Pharmaceutical co-crystal composition and related methods of use
ザウオロトコ,マイケル・ジエイ (2005)
10.1016/J.JCRYSGRO.2003.10.025
Morphology and growth control of griseofulvin recrystallized by compressed carbon dioxide as antisolvent
B. D. Gioannis (2004)
10.1002/JPS.20587
Particle size limits to meet USP content uniformity criteria for tablets and capsules.
B. Rohrs (2006)
10.1016/J.JCRYSGRO.2007.09.010
Solvent effect on tolbutamide crystallization induced by compressed CO2 as antisolvent
P. Subra-Paternault (2007)
10.1016/J.IJPHARM.2005.11.008
Experimental study of the GAS process for producing microparticles of beclomethasone-17,21-dipropionate suitable for pulmonary delivery.
Y. Bakhbakhi (2006)
10.1016/S1871-5125(09)34005-4
Chapter 5 itraconazole: comprehensive profile.
Abdullah A. Al-Badr (2009)



This paper is referenced by
10.1016/J.FJPS.2017.04.005
Studies on effect of hydrophilic polymers on physicochemical properties of itraconazole cocrystals
As Shete (2017)
10.35333/jrp.2020.163
Compression force effect on characteristics of loratadine-succinic acid cocrystal prepared by slurry method
D. Setyawan (2020)
10.1016/J.SUPFLU.2013.07.008
Naproxen–nicotinamide cocrystals produced by CO2 antisolvent
C. Neurohr (2013)
10.1016/J.JIEC.2018.01.017
Statistical optimization for production of mefenamic acid–nicotinamide cocrystals using gas anti-solvent (GAS) process
Napada Wichianphong (2018)
10.1016/j.addr.2017.07.008
Advanced methodologies for cocrystal synthesis
D. Douroumis (2017)
10.1021/ACS.CGD.8B00933
Creating Cocrystals: A Review of Pharmaceutical Cocrystal Preparation Routes and Applications
M. Karimi-Jafari (2018)
Formulation Enhancement of Poorly Water-Soluble Pharmaceuticals by CO2-Based Crystallization Technologies
Courtney A. Ober (2013)
10.22270/JDDT.V6I3.1236
SOLVENT EFFECT ON STABILIZATION OF METFORMIN MICRO PARTICLES
A. Chawla (2016)
10.1016/J.JIEC.2014.11.009
Gas anti-solvent processing of a new sulfamethoxazole−l-malic acid cocrystal
Rawin Imchalee (2015)
10.20902/ijctr.2019.130326
Pharmaceutical Co-crystal : An Emerging Technique toenhance Physicochemical properties of drugs
D. Patel (2020)
10.3390/pharmaceutics10030108
Engineering Cocrystals of Poorly Water-Soluble Drugs to Enhance Dissolution in Aqueous Medium
Indumathi Sathisaran (2018)
10.1007/s11095-016-1890-8
Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying
T. Parikh (2016)
10.1016/j.ejpb.2017.02.013
Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations
Masatoshi Karashima (2017)
10.1016/J.JCOU.2015.11.006
Pharmaceutical co-crystals of the anti-inflammatory drug diflunisal and nicotinamide obtained using supercritical CO2 as an antisolvent
Isaac A. Cuadra (2016)
10.22146/ijc.25089
Thermodynamic and Thermomicroscopy Study of Atorvastatin Calcium-Succinic Acid Binary Mixtures
Yudi Wicaksono (2017)
10.1039/C6RA10917A
Preparation of pharmaceutical co-crystals through sustainable processes using supercritical carbon dioxide: a review
C. Pando (2016)
10.1016/J.FLUID.2014.03.029
High-pressure solubility of naproxen, nicotinamide and their mixture in acetone with supercritical CO2 as an anti-solvent
Anne-Laure Revelli (2014)
10.1016/J.JCOU.2018.05.011
Application of Box–Behnken design for processing of mefenamic acid–paracetamol cocrystals using gas anti-solvent (GAS) process
Napada Wichianphong (2018)
10.1016/J.JCOU.2016.12.007
Processing of ketoconazole–4-aminobenzoic acid cocrystals using dense CO2 as an antisolvent
Gunaree Kotbantao (2017)
10.1016/J.CEJ.2016.05.129
Challenge of the supercritical antisolvent technique SAS to prepare cocrystal-pure powders of naproxen-nicotinamide
C. Neurohr (2016)
10.1016/J.SUPFLU.2018.11.014
Precipitation of resveratrol-isoniazid and resveratrol-nicotinamide cocrystals by gas antisolvent
Alcidênio Soares Pessoa (2019)
10.1080/2331205X.2018.1480572
Advanced colloidal technologies for the enhanced bioavailability of drugs
Fakhar ud Din (2018)
10.1016/j.ijpharm.2015.03.045
In-situ synchrotron wide-angle X-ray diffraction as a rapid method for cocrystal/salt screening.
Pin Dong (2015)
The production and characterisation of itraconazole multicomponent systems
A. Kozyra (2019)
10.3390/pharmaceutics11120629
Using Supercritical Fluid Technology as a Green Alternative During the Preparation of Drug Delivery Systems
Paroma Chakravarty (2019)
10.1016/J.SUPFLU.2014.12.013
Cocrystallization induced by compressed CO2 as antisolvent: Simulation of a batch process for the estimation of nucleation and growth parameters
A. Erriguible (2015)
10.1016/J.JDDST.2015.05.006
Cocrystals of itraconazole with amino acids: Screening, synthesis, solid state characterization, in vitro drug release and antifungal activity
As Shete (2015)
10.1016/j.ijpharm.2017.12.041
Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
S. M. Abuzar (2018)
SIMULTANEOUS COCRYSTALLIZATION AND MICRONIZATION OF PARACETAMOL-DIPICOLINIC ACID COCRYSTAL BY SUPERCRITICAL ANTISOLVENT (SAS)
Stevanus Hiendrawan (2016)
10.4274/tjps.16362
Physicochemical Characterization and In Vitro Dissolution Test of Quercetin-Succinic Acid Co-crystals Prepared Using Solvent Evaporation
Dwi Setyawan (2017)
10.1080/10837450.2016.1242625
Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets
Mona F. Arafa (2018)
10.1007/s00449-020-02311-x
Multiple crystallization as a potential strategy for efficient recovery of succinic acid following fermentation with immobilized cells
A. Luthfi (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar